Carcinoma of the anal canal

New England Journal of Medicine

Volumn 342, Issue 11, 2000, Pages 792-800

  Ryan, David P ^b   Compton, Carolyn C ^b   Mayer, Robert J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; MITOMYCIN;

ANUS CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HIV INFECTIONS; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEXUAL BEHAVIOR; TUMOR VIRUS INFECTIONS;

EID: 0034673752     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200003163421107     Document Type: Review

References (125)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 2000;50:7-33.
2. Kline RJ, Spencer RJ, Harrison EG Jr. Carcinoma associated with fistula-in-ano. Arch Surg 1964;89:989-94.
3. Buckwalter JA, Jurayj MN. Relationship of chronic anorectal disease to carcinoma. Arch Surg 1957;75:352-61.
4. Klotz RG Jr, Pamukcoglu T, Souilliard DH. Transitional cloacogenic carcinoma of the anal canal: clinicopathologic study of three hundred seventy-three cases. Cancer 1967;20:1727-45.
5. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14: 2527-39.
6. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-9.
7. Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg 1976;184: 422-8.
8. Frost DB, Richards PC, Montague ED, Giacco GG, Martin RG. Epidermoid cancer of the anorectum. Cancer 1984;53:1285-93.
9. Greenall MJ, Quan SH, Stearns MW, Urmacher C, DeCosse JJ. Epidermoid cancer of the anal margin: pathologic features, treatment, and clinical results. Am J Surg 1985;149:95-101.
10. Pintor MP, Northover JM, Nicholls RJ. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg 1989;76:806-10.
11. Boman BM, Moertel CG, O'Connell MJ, et al. Carcinoma of the anal canal: a clinical and pathologic study of 188 cases. Cancer 1984;54:114-25.
12. Schlienger M, Krzisch C, Pene F, et al. Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys 1989;17:1141-51.
13. Touboul E, Schlienger M, Buffat L, et al. Epidermoid carcinoma of the anal canal: results of curative-intent radiation therapy in a series of 270 patients. Cancer 1994;73:1569-79.
14. Singh R, Nime F, Mittelman A. Malignant epithelial tumors of the anal canal. Cancer 1981;48:411-5.
15. Schneider TC, Schulte WJ. Management of carcinoma of anal canal. Surgery 1981;20:729-34.
16. Schraut WH, Wang CH, Dawson PJ, Block GE. Depth of invasion, location, and size of cancer of the anus dictate operative treatment. Cancer 1983;51:1291-6.
17. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987;317: 973-7.
18. Holly EA, Whittemore AS, Aston DA, Ahn DK, Nickoloff BJ, Kristiansen JJ. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 1989;81:1726-31.
19. Frisch M, Olsen JH, Bautz A, Melbye M. Benign anal lesions and the risk of anal cancer. N Engl J Med 1994;331:300-2.
20. Preston DM, Fowler EF, Lennard-Jones JE, Hawley PR. Carcinoma of the anus in Crohn's disease. Br J Surg 1983;70:346-7.
21. Slater G, Greenstein A, Aufses AH Jr. Anal carcinoma in patients with Crohn's disease. Ann Surg 1984;199:348-50.
22. Daly JJ, Madrazo A. Anal Crohn's disease with carcinoma in situ. Dig Dis Sci 1989;25:464-6.
23. Daling JR, Weiss NS, Klopfenstein LL, Cochran LE, Chow WH, Daifuku R. Correlates of homosexual behavior and the incidence of anal cancer. JAMA 1982;247:1988-90.
24. Peters RK, Mack TM. Patterns of anal carcinoma by gender and marital status in Los Angeles County. Br J Cancer 1983;48:629-36.
25. Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 1994; 139:772-80.
26. Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ 1993;306:419-22.
27. Rabkin CS, Yellin F. Cancer incidence in a population with high prevalence of HIV-1 infection. Proc Am Assoc Cancer Res 1994;35:251. abstract.
28. Critchlow CW, Surawicz CM, Holmes KK, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995;9:1255-62.
29. Frisch M, Glimelius B, van den Brule AJC, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337:1350-8.
30. Peters RK, Mack TM, Bernstein L. Parallels in the epidemiology of selected anogenital carcinomas. J Natl Cancer Inst 1984;72:609-15.
31. Melbye M, Sprogel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991;338:657-9.
32. Frisch M, Olsen JH, Melbye M. Malignancies that occur before and after anal cancer: clues to their etiology. Am J Epidemiol 1994;140:12-9.
33. Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol 1992;136:54-8.
34. Palefsky JM, Holly EA, Gonzales J, Berline J, Ahn DK, Greenspan JS. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res 1991;51:1014-9.
35. Shroyer KR, Kim JG, Manos MM, Greer CE, Pearlman NW, Franklin WA. Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma. Arch Surg 1992;127:741-4.
36. Zaki SR, Judd R, Coffield LM, Greer P, Rolston F, Evatt BL. Human papillomavirus infection and anal carcinoma: retrospective analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol 1992; 140:1345-55.
37. Noffsinger AE, Suzuk L, Hui YZ, Gal AA, Fenoglio-Preiser CM. Differential sensitivities of E6 type-specific and L1 consensus primers in the detection of human papillomavirus in anal carcinoma. Mod Pathol 1995; 8:509-14.
38. Vincent-Salomon A, de la Rochefordiere A, Salmon R, Validire P, Zafrani B, Sastre-Garau X. Frequent association of human papillomavirus 16 and 18 DNA with anal squamous cell and basaloid carcinoma. Mod Pathol 1996;9:614-20.
39. Fenger C. Anal neoplasia and its precursors: facts and controversies. Semin Diagn Pathol 1991;8:190-201.
40. Duggan MA, Boras VF, Inoue M, McGregor SE, Robertson DI. Human papillomavirus DNA determination of anal condylomata, dysplasias, and squamous carcinomas with in situ hybridization. Am J Clin Pathol 1989;92:16-21.
41. Palefsky J. Human papillomavirus infection among HIV-infected individuals: implications for development of malignant tumors. Hematol Oncol Clin North Am 1991;5:357-70.
42. Williams GR, Lu QL, Love SB, Talbot IC, Northover JM. Properties of HPV-positive and HPV-negative anal carcinomas. J Pathol 1996;180: 378-82.
43. Penn I. Cancers of the anogenital region in renal transplant recipients: analysis of 65 cases. Cancer 1986;58:611-6.
44. Arends MJ, Benton EC, McLaren KM, Stark LA, Hunter JA, Bird CC. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer 1997:75: 722-8.
45. Sillman F, Stanek A, Sedlis A, et al. The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosup-pressed women. Am J Obstet Gynecol 1984;150:300-8.
46. Sillman FH, Sedlis A. Anogenital papillomavirus infection and neoplasia in immunodeficient women: an update. Dermatol Clin 1991;9:353-69.
47. Sillman FH, Fruchter RG, Chen YS, Camilien L, Sedlis A, McTigue E. Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion and its management. Am J Obstet Gynecol 1997;176:93-9.
48. Caussy D, Goedert JJ, Palefsky J, et al. Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men. Int J Cancer 1990;46:214-9.
49. Kiviat N, Rompalo A, Bowden R, et al. Anal human papillomavirus infection among human immunodeficiency virus-seropositive and -sero-negative men. J Infect Dis 1990;162:358-61.
50. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:205-11.
51. Palefsky JM, Holly EA, Ralston ML, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:320-6.
52. Sun X-W, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-9.
53. Palefsky JM, Holly EA, Hogcboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HTV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:314-9.
54. Selik RM, Rabkin CS. Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 1998;90:1300-2.
55. Melbye M, Cote TR, Kessler L, Gail M, Biggar RJ. High incidence of anal cancer among AIDS patients. Lancet 1994;343:636-9.
56. Biggar RJ, Burnett W, Mikl J, Nasca P. Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 1989;43: 979-85.
57. Biggar RJ, Horm J, Goedert JJ, Melbye M. Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol 1987;126:578-86.
58. Harnly ME, Swan SH, Holly EA, Kelter A, Padian N. Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome. Am J Epidemiol 1988;128:261-7.
59. Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 1994;86:1711-6.
60. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet 1998;351:1833-9.
61. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999;281:1822-9.
62. Holmes F, Borek D, Owen-Kummer M, et al. Anal cancer in women. Gastroenterology 1988;95:107-11.
63. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992;135:180-9.
64. Greenall MJ, Quan SH, Urmacher C, DeCosse JJ. Treatment of epidermoid carcinoma of the anal canal. Surg Gynecol Obstet 1985;161:509-17.
65. Dougherty BG, Evans HL. Carcinoma of the anal canal: a study of 79 cases. Am J Clin Pathol 1985;83:159-64.
66. Puthawala AA, Syed AM, Gates TC, McNamara C. Definitive treatment of extensive anorectal carcinoma by external and interstitial irradiation. Cancer 1982;50:1746-50.
67. Cummings BJ, Thomas GM, Keane TJ, Harwood AR, Rider WD. Primary radiation therapy in the treatment of anal canal carcinoma. Dis Colon Rectum 1982;25:778-82.
68. Cantril ST, Green JP, Schall GI., Schaupp WC. Primary radiation therapy in the treatment of anal carcinoma. Int J Radiat Oncol Biol Phys 1983; 9:12718.
69. Papillon J, Mayer M, Montbarbon JF, Gerard JP, Chassard JL, Bailly C. A new approach to the management of epidermoid carcinoma of the anal canal. Cancer 1983;51:1830-7.
70. Doggert SW, Green JP, Cantril ST. Efficacy of radiation therapy alone for limited squamous cell carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1988;15:1069-72.
71. Hughes LL, Rich TA, Delclos L, Ajani JA, Martin RG. Radiotherapy for anal cancer: experience from 1979-1987. Int J Radiat Oncol Biol Phys 1989;17:1153-60.
72. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991;21:1115-25.
73. Dubois JB, Garrigues JM, Pujol H. Cancer of the anal canal: report on the experience of 61 patients. Int J Radiat Oncol Biol Phys 1991;20: 575-80.
74. Martenson JA Jr, Gunderson LL. External radiation therapy without chemotherapy in the management of anal cancer. Cancer 1993;71:1736-40.
75. Allal A, Kurtz JM, Pipard G, et al. Chemoridiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys 1993;27:59-66.
76. Eschwege F, Lasser P, Chavy A, et al. Squamous cell carcinoma of the anal canal: treatment by external beam irradiation. Radiother Oncol 1985; 3:145-50.
77. Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DcLaney TF. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 1997;39:651-7.
78. Wagner JP, Mahe MA, Romestaing P, et al. Radiation therapy in the conservative treatment of carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1994;29:17-23.
79. Allal AS, Mermillod B, Roth AD, Marti MC, Kurtz JM. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 1997;39:1099-105.
80. John M, Pajak T, Flam M, et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am 1996;2: 205-11.
81. Foye LV Jr, Willett FM, Hall B, Roth M. The potcntiation of radiation effects with 5-fluorouracil. Cancer Chemother Rep 1960;6:12-5.
82. Allaire FJ, Thieme ET, Korst DR. Cancer chemotherapy with 5-fluorouracil alone and in combination with x-ray therapy. Cancer Chemother Rep 1961;14:59-75.
83. Frank W, Newcomer KL, Cirksena WJ, et al. Further observations on the concomitant use of x rays and 5-fluorouracil in neoplasms of humans. Cancer Chemother Rep 1962;22:55-8.
84. Childs DS Jr, Moertel CG, Holbrook MA, Reitemeier RJ, Colby M Jr. Treatment of unresectable adenocarcinomas of the stomach with a combination of 5-fluorouracil and radiation. AJR Am J Roentgenol 1968;102: 541-4.
85. Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY Jr, Holbrook MA. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865-7.
86. Henderson IW, Lipowska B, Lougheed MN. Clinical evaluation of combined radiation and chemotherapy in gastrointestinal malignancies. AJR Am J Roentgenol 1968;102:545-51.
87. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17: 354-6.
88. Leichman L, Nigro N, Vaitkevicius VK, et al. Cancer of the anal canal: model for preoperative adjuvant combined modality therapy. Am J Med 1985;78:211-5.
89. Doci R, Zucali R, Bombelli L, Montalto F, Lamonica G. Combined chemoradiation therapy for anal cancer: a report of 56 cases. Ann Surg 1992;215:150-6.
90. Doci R, Zucali R, La Monica G, et al. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol 1996;14:3121-5.
91. Sischy B, Doggett RL, Krall JM, et al. Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst 1989;81:850-6.
92. Martenson JA, Lipsitz SR, Wagner H Jr, et al. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. Int J Radiat Oncol Biol Phys 1996;35:745-9.
93. Martenson JA, Lipsitz SR, Lefkopoulou M, et al. Results of combined modality therapy for patients with anal cancer (E7283): an Eastern Cooperative Oncology Group study. Cancer 1995;76:1731-6.
94. Enker WE, Heilwell M, Janov AJ, et al. Improved survival in epidermoid carcinoma of the anus in association with preoperative multidisciplinary therapy. Arch Surg 1986;121:1386-90.
95. Michaelson RA, Magill GB, Quan SH, Learning RH, Nikrui M, Stearns MW. Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma. Cancer 1983;51:390-5.
96. Nigro ND. Multidisciplinary management of cancer of the anus. World J Surg 1987;11:446-51.
97. Idem. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 1984;27:763-6.
98. Nigro ND, Seydel HG, Considine B, Vaitkevicius VK, Leichman L, Kinzie JJ. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983;51:1826-9.
99. Sischy B. The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 1985;11:1587-93.
100. Sischy B, Remington JH, Hinson EJ, Sobel SH, Woll JE. Definitive treatment of anal-canal carcinoma by means of radiation therapy and chemotherapy. Dis Colon Rectum 1982;25:685-8.
101. John MJ, Flam M, Lovalvo L, Mowry PA. Feasibility of non-surgical definitive management of anal canal carcinoma. Int J Radiat Oncol Biol Phys 1987;13:299-303.
102. Flam MS, John M, Lovalvo LJ, et al. Definitive nonsurgical therapy of epithelial malignancies of the anal canal: a report of 12 cases. Cancer 1983;51:1378-87.
103. Cummings B, Keane T, Thomas G, Harwood A, Rider W. Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer 1984;54:2062-8.
104. Fung CY, Willett CG, Efird JT, et al. Chemoradiotherapy for anal carcinoma: what is the optimal radiation dose? Radiat Oncol Invest 1994; 2:152-6.
105. Johnson D, Lipsett J, Leong L, Wagman LD, Terz JJ. Carcinoma of the anus treated with primary radiation therapy and chemotherapy. Surg Gynecol Obstet 1993;177:329-34.
106. Meeker WR Jr, Sickle-Santanello BJ, Philpott G, et al. Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal. Cancer 1986;57:525-9.
107. John M, Flam M, Palma N. Ten-year results of chemoradiation for anal cancer: focus on late morbidity. Int J Radiat Oncol Biol Phys 1996; 34:65-9.
108. Nigh SS, Smalley Sr, Elman AJ, et al. Conservative therapy for anal carcinoma: an analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1991;21:Suppl 1:224. abstract.
109. Chadha M, Rosenblatt EA, Malamud S, Pisch J, Berson A. Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum 1994;37:861-5.
110. Peddada AV, Smith DE, Rao AR, Frost DB, Kagan AR. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1997;37: 1101-5.
111. Hoffman R, Welton ML, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 1999;44:127-31.
112. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;348:1049-54.
113. Sheldon R, Slaughter D. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary ederna in chemotherapy-treated patients with adenocarcinoma. Cancer 1986;58:1428-36.
114. Verwey J, de Vries J, Pinedo HM. Mitomycin C-induced renal toxicity, a dose-dependent side effect? Eur J Cancer Clin Oncol 1987;23:195-9.
115. Lesesne JB, Rothschild N, Erickson B, et al. Cancer-associated hemolytk-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989;7:781-9.
116. Chang AY, Kuebler JP, Pandya KJ, Israel RH, Marshall BC, Tormey DC. Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids. Cancer 1986;57:2285-90.
117. Verweij J, van Zanten T, Souren T, Golding R, Pinedo HM. Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis. Cancer 1987;60:756-61.
118. Kantarjian HM, Kcating MJ, Walters RS, et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol 1986-4:1748-57.
119. Pedersen-Bjergaard J, Philip P, Larsen SO, et al. Therapy-related myelodysplasia and acute myeloid leukemia: cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993;7:1975-86.
120. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. Classic Pap Curr Comments Highlights Gastrointest Cancer Res 1999;3:539-52.
121. Peiffert D, Seitz JF, Rougier P, et al. Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal can cer: a French cooperative study. Ann Oncol 1997;8:575-81.
122. Pocard M, Tiret E, Nugent K, Dehni N, Pare R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 1998;41:1488-93.
123. Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti MC. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 1999;86:405-9.
124. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999;85:1686-93.
125. Tanum G, Tveit K, Karlsen KO, Hauer-Jensen M. Chemotherapy and radiation therapy for anal carcinoma: survival and late morbidity. Cancer 1991;67:2462-6.